Interaction with components of the complement system is an important aspect of the pathogenesis of infection by Candida albicans. The key role of C3 . These results suggest that the alternative complement pathway is the primary mechanism for activation and binding of C3 fragments to C. albicans. Bound C3 could be partially removed (50%) by treatment with 1.0 M hydroxylamine. In contrast, 1.0 M hydroxylamine removed 98% of the C3 fragments bound to encapsulated Cryptococcus neoformans. These results suggest that ester bonds are the primary mechanism for binding C3 to C. neoformans, whereas binding of C3 to C. albicans involves both ester and amide bonds. Monoclonal antibodies specific for C3c and an iC3b neoantigen were used to identify the fragment of C3 that was bound to C. albicans. The results showed that the primary fragment bound to the yeast was C3b. An examination of the kinetics of activation and binding of C3 fragments showed that activation and binding were very rapid. Near-maximal binding occurred after a 2.5-to 5-min incubation period. In contrast, activation and binding of C3 fragments to C. neoformans proceeded at a slower rate, with maximal binding requiring 10 to 20 min. These results indicate that activation and binding of C3 fragments by the yeasts C. albicans and C. neoformans differ in several important characteristics.
Interaction with components of the complement system is an important aspect of the pathogenesis of infection by Candida albicans. The key role of C3 as an opsonic ligand and as an element in amplification of complement activation led us to examine several factors that influence the activation and binding of C3 cleavage fragments to the yeast. Activation and binding of C3 were determined by use of normal human serum containing '251-labeled C3. Incubation of yeast-phase cells in 20% serum led to deposition of 2.5 x 105 to 3.0 x 105 molecules of C3 per yeast cell. Binding of C3 was absent in serum that was heat inactivated for 30 min at 37°C or in serum that was chelated with EDTA. Chelation of serum with EGTA [ethylene glycol-bis(O-aminoethyl ether)-N,N,N',N'-tetraacetic acid] reduced binding of C3 fragments by 31%. These results suggest that the alternative complement pathway is the primary mechanism for activation and binding of C3 fragments to C. albicans. Bound C3 could be partially removed (50%) by treatment with 1.0 M hydroxylamine. In contrast, 1.0 M hydroxylamine removed 98% of the C3 fragments bound to encapsulated Cryptococcus neoformans. These results suggest that ester bonds are the primary mechanism for binding C3 to C. neoformans, whereas binding of C3 to C. albicans involves both ester and amide bonds. Monoclonal antibodies specific for C3c and an iC3b neoantigen were used to identify the fragment of C3 that was bound to C. albicans. The results showed that the primary fragment bound to the yeast was C3b. An examination of the kinetics of activation and binding of C3 fragments showed that activation and binding were very rapid. Near-maximal binding occurred after a 2.5-to 5-min incubation period. In contrast, activation and binding of C3 fragments to C. neoformans proceeded at a slower rate, with maximal binding requiring 10 to 20 min. These results indicate that activation and binding of C3 fragments by the yeasts C. albicans and C. neoformans differ in several important characteristics.
Interaction with components of the complement system is an important aspect of the pathogenesis of Candida albicans infection. Whole yeast cells and extracts from yeast cell walls activate the complement cascade (20, 21, 28) . The importance of the complement system is demonstrated by the increased susceptibility to candidiasis of animals depleted of alternative pathway activity by treatment with cobra venom factor (7) .
Phagocytosis of C. albicans yeast cells is critically dependent upon opsonization by components of the complement cascade. Little phagocytosis occurs without opsonization with serum components (25) . Moreover, the opsonic activity of serum is markedly reduced by heat inactivation at 56°C (3, 23, 25) or 50°C (16) . Serum chelated with 10 mM ethylene glycol-bis(q-aminoethyl ether)-N,N,N',N'-tetraacetic acid containing 10 mM MgCl2 (magnesium EGTA) would support phagocytosis of the yeast, whereas serum chelated with EDTA showed no opsonic activity (8, 16, 25) . Taken together, these reports provide strong evidence that the alternative complement pathway is the mechanism for opsonization of C. albicans yeast cells by normal serum.
The importance of C3 in phagocytosis of C. albicans was demonstrated by Morrison and Cutler (16) , who found that serum depleted of C3 would not opsonize C. albicans for phagocytosis. Complement component C3 plays a key role in amplification of the complement cascade. In addition, cleavage fragments of C3 can act as opsonic ligands for phagocytosis (24) . These properties of C3 led us to examine the factors that influence the binding of C3 cleavage fragments to C. albicans. We assessed the ability of serum from normal individuals to deposit C3 fragments on C. albicans.
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The objectives of our study were (i) to determine the role of the alternative pathway in activation and binding of C3 to C. albicans, (ii) to identify the mechanism by which C3 fragments are bound to C. albicans, (iii) to identify the fragment(s) of C3 that is bound to C. albicans, and (iv) to determine the time course of activation and binding of C3 fragments. The results showed that C3 fragments are activated and bound from normal human serum onto C. albicans. However, C. albicans differs in several key characteristics from Cryptococcus neoformans, another activator of the complement cascade. 10 mM MgCI2, and 10 mM EGTA).
MATERIALS AND METHODS
Serum and serum proteins. Normal human serum samples were obtained from 10 volunteers after their informed consent was obtained. The sera were poQled, and portions were stored at -70°C. For some studies, the serum was heated at 56°C for 30 min. C3 was isolated from frozen human plasma as previously described (11) . Any contaminating immunoglobulin G in the C3 preparation was removed by adsorption with protein A-Sepharose, followed by adsorption on an anti-immunoglobulin G column (26) . Analysis of reduced preparations of C3 by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis showed the presence of two bands characteristic of the alpha and beta chains of C3 (26) and the absence of any detectable contaminating proteins.
C3 was labeled with 1251 by the lodogen procedure (Pierce Chemical Co., Rockford, Ill.) as previously described (5). Labeled C3 was separated from free iodine by gel filtration through Sephadex G-25. Typically, 1.0 mg of C3 was labeled with an efficiency of 80% to a specific activity of 5 x 105 cpm/,ug. Radiolabeled C3 remained functionally active for at least 7 days but was used within 4 days.
Antibodies. A monoclonal antibody specific for C3c was purchased from Genzyme Corp., Boston, Mass. A monoclonal antibody specific for iC3b neoantigen (27) with normal human serum containing '25I-labeled C3 in the manner described above. The cells were washed five times with PBS-SDS. The amount of bound C3 was determined, and the yeast cells were incubated for 60 min at 37°C with 2.5 ml of (i) PBS-SDS, (ii) 1 M NH2OH in 0.2 M NaHCO3 (pH 10.0), or (iii) 3.5 M NaSCN (pH 7.0). The treated yeast cells were washed twice with PBS-SDS, and the amount of remaining C3 was determined. The amount of released C3 was calculated, and the data are reported as the percentage of C3 removed after treatment with NH2OH or NaSCN relative to the amount of C3 remaining after treatment with PBS-SDS.
RESULTS
Previous studies have shown that effective opsonization of C. albicans by heat-labile opsonins was due to activation of the alternative complement pathway. An experiment was done to assess the roles of the classical and alternative pathways in activation and deposition of C3 onto yeast cells. Candida cells were incubated with normal human serum, heat-inactivated (56°C for 30 min) human serum, normal human serum chelated with EDTA, or human serum treated with magnesium EGTA. Radiolabeled C3 was added to each serum source as a marker for C3 binding. EGTA chelates Ca2 , which is necessary for activation of the classical complement pathway (4, 19) . Activation of the alternative pathway occurs in the presence of magnesium EGTA because the alternative pathway requires Mg2+ for activation but not Ca2+ (4, 19 Binding of C3 to a substrate can occur via an ester bond or an amide bond (6, 12, 13) . Ester bonds are quite sensitive to hydrolysis with hydroxylamine, whereas amide bonds are relatively resistant to hydroxylamine (12) (13) (14) . Alternatively, the C3 could be bound to antibody, which in turn is bound to the yeast cells. As The previous experiments demonstrated that some form of C3 was bound to C. albicans, but the molecular form of the bound C3 fragment was not identified. Monoclonal antibodies specific for C3c and iC3b neoantigen were used as probes for the molecular form of the bound C3 fragments. Anti-C3c is reactive with C3b and iC3b (17). In contrast, anti-iC3b neoantigen is not reactive with C3b but is reactive with iC3b (27) . Candidal yeast cells were incubated with normal human serum for 2.5 to 40 min. The reaction was stopped, and the yeast cells were washed and incubated with saturating amounts of 1251-labeled anti-C3c or anti-iC3b neoantigen. The results (Fig. 1) showed rapid activation and binding of C3 fragments to the yeast cells, as shown by the binding of anti-C3c to the serum-treated yeast cells. Very little antiiC3b neoantigen bound to candidal cells that were incubated with normal human serum, indicating little conversion of bound C3b to iC3b (27) . As a positive control for the reactivity of the anti-iC3b neoantigen, cryptococci were incubated with normal human serum, washed, and incubated with the radiolabeled anti-iC3b neoantigen, and the bound radioactivity was determined. The results (data not shown) showed appreciable conversion of C3b to iC3b. Previous studies have shown that large amounts of C3b bound to the cryptococcal capsule are converted to iC3b (11) .
The rapid activation and binding of C3b to C. albic-ans shown by the anti-C3c antibody probe suggested a much more rapid activation kinetics than has been observed for C. neoformnans (11) . This rapid activation was confirmed by comparing the activation and binding of t25I-labeled C3 from normal human serum onto C. albicans and C. neqofrmans (Fig. 2) . Incubation of C. albicans in human serum containing 1251I-labeled C3 for 2.5 to 40 min showed that 64% of the maximum binding of C3 fragments occurred after a 2.5-min incubation period. In contrast, only 42% of maximum binding of C3 fragments to C. neoforinans had occurred after a 10-min incubation period. 
DISCUSSION
Yeast cell walls have been studied as activators of the complement cascade for many years. Indeed, zymosan is the prototype of the particulate activator of the alternative complement pathway. Our studies demonstrate that marked differences may occur in the manner in which C3 is activated and bound to pathogenic yeasts. Activation and binding of C3 fragments to C. allbicalns and C. neoftn'mans are compared in Table 3 .
The polysaccharide capsule is the site for activation and binding of C3 fragments to C. neoforinans. Ultrastructural studies have shown that C3 binds predominantly to the periphery of the capsule, with little C3 bound deep within the capsule or at the cell wall (9) . C. albicans lacks a capsule; consequently, the cell wall is the only structure available for activation and binding of C3. The cryptococcal capsule is a large, three-dimensional matrix which presents a much larger surface area for C3 binding than would be available on the two-dimensional structure presented by the candidal cell wall. This undoubtedly accounts in a large part for the much greater amount of C3 that binds to C. neoformans. Results of other quantitative studies of binding of C3 to nonencapsulated yeasts more closely resemble the numbers of C3 molecules binding to C. albicans than C. neoformans. For example, Newman and Mikus report 7 x 104 to 9 x 104 C3 molecules bound per cell of bakers' yeast (17).
C3 was bound to C. albicans by both hydroxylaminesensitive and hydroxylamine-resistant bonds. In contrast, the C3 bound to C. neoformans was completely sensitive to hydrolysis with hydroxylamine. Previous studies have shown that hydroxylamine-sensitive bonds are most likely to be ester bonds between C3 fragments and hydroxyl groups on receptive molecules (6, 12, 13) . Hydroxylamine-resistant bonds are most likely due to amide bonds between C3 fragments and receptive molecules (12) (13) (14) . The absence of amide bonds between C3 and C. neoformans is probably due to the absence of appropriate amino groups in cryptococcal capsular polysaccharide (1) . Previous ultrastructural studies have shown that C3 binds to the periphery of the capsule, an area that would be relatively free of amino groups. C. albicans, in contrast, lacks a capsule, and the cell wall is the most likely binding site for C3. The source of available amino groups is not known for the candidal cell wall; however, the composition of the cell wall of C. albicans does include protein (22) .
C. albicans and C. neoformans exhibit qualitative differences in the C3 fragments that are bound to the yeast cells. These qualitative differences suggest that complement activation is regulated differently on the two yeasts. The absence of iC3b on C. albicans suggests that complement activation is not regulated by factors H and I. Presumably, activation proceeds in a relatively unrestricted manner until saturating amounts of C3b have been deposited on the yeast surface. In contrast, the presence of iC3b on C. neoformans indicates that factors H and I effect the decay of a portion of C3b as it is formed. The molecular differences between the surfaces of the two yeasts that account for this differential regulation are not known.
The relatively slow activation kinetics by C. neoformans may be a reflection of the decay of C3b to iC3b in the cryptococcal capsule. Conversion of C3b to iC3b may inhibit the rate of activation to some extent. C. albicans, in contrast, exhibits little or no decay of C3b to iC3b; thus, the rate of the reaction may be faster. Alternatively, the slow reaction kinetics by cryptococci may be due to the three-dimensional nature of the cryptococcal capsule. It 
